# Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ruxolitinib-in-treatment-of-severe-coronavirus-disease-2019-covid-19-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yang Cao,Jia Wei,Liang Zou,Tiebin Jiang,Gaoxiang Wang,Liting Chen,Liang Huang,Fankai Meng,Lifang Huang,Na Wang,Xiaoxi Zhou,Hui Luo,Zekai Mao,Xing Chen,Jungang Xie,Jing Liu,Hui Cheng,Jianping Zhao,Gang Huang,Wei Wang,Jianfeng Zhou |
| Citations | 475 |
| DOI | 10.1016/j.jaci.2020.05.019 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jacionline.org/article/S0091674920307387/pdf |
| OpenAlex ID | https://openalex.org/W3030158388 |
| PMID | 32470486 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Wei Wang](https://scholariq.org/researchers/wei-wang-4/)

## Paper journal

- [Journal of Allergy and Clinical Immunology](https://scholariq.org/journals/journal-of-allergy-and-clinical-immunology/)

## Paper primary topic

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Paper topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Cytokine Signaling Pathways and Interactions](https://scholariq.org/topics/cytokine-signaling-pathways-and-interactions/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.